Your browser doesn't support javascript.
loading
Postmarketing safety and effectiveness of recombinant factor IX (nonacog alfa) in Japanese patients with haemophilia B.
Fukutake, Katsuyuki; Taki, Masashi; Matsushita, Tadashi; Sakai, Michio; Takata, Ami; Yamaguchi, Hiromi; Karumori, Toshiyuki.
Affiliation
  • Fukutake K; Department of Laboratory Medicine, Tokyo Medical University, Tokyo, Japan.
  • Taki M; Department of Molecular Genetics of Coagulation Disorders, Tokyo Medical University, Tokyo, Japan.
  • Matsushita T; Department of Pediatrics, St. Marianna University School of Medicine, Yokohama City Seibu Hospital, Yokohama, Japan.
  • Sakai M; Department of Transfusion Medicine, Nagoya University Hospital, Nagoya, Japan.
  • Takata A; Department of Pediatrics, University of Occupational and Environmental Health, Kitakyushu, Japan.
  • Yamaguchi H; Pfizer Japan, Tokyo, Japan.
  • Karumori T; Pfizer Japan, Tokyo, Japan.
Haemophilia ; 25(4): e247-e256, 2019 Jul.
Article in En | MEDLINE | ID: mdl-31168882
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Product Surveillance, Postmarketing / Safety / Recombinant Proteins / Factor IX / Hemophilia B Type of study: Observational_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2019 Document type: Article Affiliation country: Japón
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Product Surveillance, Postmarketing / Safety / Recombinant Proteins / Factor IX / Hemophilia B Type of study: Observational_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2019 Document type: Article Affiliation country: Japón